Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01749059 · ClinicalTrials.gov registry record
The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease
A clinical trial of Congenital Heart Disease, sponsored by Pediatrix.
- Completed
- Registry status
- 6,147
- Enrollment target
- 1
- Study location
NCT01749059: Completed study of Congenital Heart Disease, sponsored by Pediatrix.
NCT01749059 is a study of Congenital Heart Disease that has completed, run by Pediatrix. The registered enrollment target is 6,147 participants, above the 376-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (1535% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01749059, a study of Congenital Heart Disease, has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 6,147 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the impact of implementing a universal pulse oximeter screening as a way to detect critical congenital heart disease in otherwise well-appearing newborns.
Primary Outcome
The numbers of subjects who have a positive pulse oximetry screening test and who in follow-up evaluation are found to have CCHD.
Conditions Studied
Study Locations (1)
New Jersey
- Capital Health Regional Medical Center - Pediatrix Medical Group - Trenton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,147 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-10 |
What the finished NCT01749059 record still lists
NCT01749059 is an observational study that tracks outcomes without assigning an intervention. Its 6,147 participants enrollment target places it among the larger protocols in the corpus, above the 376-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (1535% higher).
The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01749059 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT01749059 about?
NCT01749059 is a clinical study titled "The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease". The purpose of this study is to evaluate the impact of implementing a universal pulse oximeter screening as a way to detect critical congenital heart disease in otherwise well-appearing newborns.
What is the current status of trial NCT01749059?
This trial is currently completed. The enrollment target is 6,147 participants. The study started on 2012-06. Estimated completion is 2016-10.
What conditions does trial NCT01749059 study?
This clinical trial studies the following conditions: Congenital Heart Disease.
Who is sponsoring clinical trial NCT01749059?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01749059 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01749059's enrollment target sits among peer trials
6,147 2nd of 63 the highest of 63 other Congenital Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
PDA for Kidneys Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04774159 · 6,150 participants · Phase 3
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- NCT06304168 · 6,150 participants
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
- NCT07049861 · 6,200 participants · NA
Advancing Biopsychosocial Care Training Initiative
- NCT07166861 · 6,080 participants · NA
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia